In the COVID-19 Era, In-Person Prenatal Visits Remain Safe

Among pregnant women, COVID-19 status was unrelated to the number of prenatal visits, suggesting that such visits are not risky for SARS-CoV-2 infection.

Concern about acquiring COVID-19 may dissuade people from attending medical appointments for other health issues. As pregnant women are scheduled for frequent in-person visits, investigators assessed whether the number of prenatal visits beginning in mid-March 2020 (the probable initial period of SARS-CoV-2 community transmission in Boston) was associated with risk for SARS-CoV-2 infection.

Mean number of in-person visits was 3.1 among the 93 women who tested positive for COVID-19 and 3.3 among 372 matched controls (women who tested negative).

Reviewing Author

Anna Wald, MD, MPH

Disclosures

Consultant/Advisory BoardAicuris; Bayer; GSK; Innovative Molecules; Merck; MAPP Biopharmaceutical (Safety Monitoring Committee)

RoyaltiesUpToDate

Grant/Research SupportNIH/National Institute of Allergy and Infectious Diseases; GSK; Moderna; Assembly Biomedical; Aicuris

Editorial BoardsSexually Transmitted Diseases; Sexually Transmitted Infections; Journal of Infectious Diseases

Leadership PositionsID Division Chiefs Community of Practice (At-Large Member)